Form 8-K - Current report:
SEC Accession No. 0001564590-22-020824
Filing Date
2022-05-20
Accepted
2022-05-20 10:30:43
Documents
14
Period of Report
2022-05-20
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K txmd-8k_20220520.htm   iXBRL 8-K 36633
2 EX-99.1 txmd-ex991_6.htm EX-99.1 11226
3 GRAPHIC gtfmzuf5gqqc000001.jpg GRAPHIC 6973
  Complete submission text file 0001564590-22-020824.txt   190961

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA txmd-20220520.xsd EX-101.SCH 5613
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20220520_lab.xml EX-101.LAB 19320
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20220520_pre.xml EX-101.PRE 11504
8 EXTRACTED XBRL INSTANCE DOCUMENT txmd-8k_20220520_htm.xml XML 3547
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 22946089
SIC: 2834 Pharmaceutical Preparations